Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Sun Yat-sen University
Sponsor:
Information provided by (Responsible Party):
Yunfei Yuan, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT01642446
First received: July 12, 2012
Last updated: October 14, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2022
  Estimated Primary Completion Date: June 2022 (Final data collection date for primary outcome measure)